DPYD, TYMS, TYMP, TK1, and TK2 Genetic Expressions as Response Markers in Locally Advanced Rectal Cancer Patients Treated with Fluoropyrimidine-Based Chemoradiotherapy
Figure 1
Schematic representations of weighted enzymatic chip array and gene expression patterns of responders and nonresponders. (a) Schematic representation of weighted enzymatic chip array including 5 target genes, one housekeeping gene (β-actin), one negative control gene (Negative), and one blank control (Blank). Five target genes (DPYD, TYMS, TYMP, TK1, and TK2). (b) A triplicate set of 5 genetic biomarkers for locally advanced rectal cancer patients with response and nonresponse is shown on the nylon membrane.
